ATE448224T1 - Carbamatverbindungen als agonisten am 5-ht4- rezeptor - Google Patents

Carbamatverbindungen als agonisten am 5-ht4- rezeptor

Info

Publication number
ATE448224T1
ATE448224T1 AT06838207T AT06838207T ATE448224T1 AT E448224 T1 ATE448224 T1 AT E448224T1 AT 06838207 T AT06838207 T AT 06838207T AT 06838207 T AT06838207 T AT 06838207T AT E448224 T1 ATE448224 T1 AT E448224T1
Authority
AT
Austria
Prior art keywords
carbamat
agonists
receptor
compounds
carbamat compounds
Prior art date
Application number
AT06838207T
Other languages
English (en)
Inventor
Daniel Long
Seok-Ki Choi
Paul R Fatheree
Adam Goldblum
Daniel Marquess
Original Assignee
Theravance Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Theravance Inc filed Critical Theravance Inc
Application granted granted Critical
Publication of ATE448224T1 publication Critical patent/ATE448224T1/de

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D451/00—Heterocyclic compounds containing 8-azabicyclo [3.2.1] octane, 9-azabicyclo [3.3.1] nonane, or 3-oxa-9-azatricyclo [3.3.1.0<2,4>] nonane ring systems, e.g. tropane or granatane alkaloids, scopolamine; Cyclic acetals thereof
    • C07D451/02—Heterocyclic compounds containing 8-azabicyclo [3.2.1] octane, 9-azabicyclo [3.3.1] nonane, or 3-oxa-9-azatricyclo [3.3.1.0<2,4>] nonane ring systems, e.g. tropane or granatane alkaloids, scopolamine; Cyclic acetals thereof containing not further condensed 8-azabicyclo [3.2.1] octane or 3-oxa-9-azatricyclo [3.3.1.0<2,4>] nonane ring systems, e.g. tropane; Cyclic acetals thereof
    • C07D451/04—Heterocyclic compounds containing 8-azabicyclo [3.2.1] octane, 9-azabicyclo [3.3.1] nonane, or 3-oxa-9-azatricyclo [3.3.1.0<2,4>] nonane ring systems, e.g. tropane or granatane alkaloids, scopolamine; Cyclic acetals thereof containing not further condensed 8-azabicyclo [3.2.1] octane or 3-oxa-9-azatricyclo [3.3.1.0<2,4>] nonane ring systems, e.g. tropane; Cyclic acetals thereof with hetero atoms directly attached in position 3 of the 8-azabicyclo [3.2.1] octane or in position 7 of the 3-oxa-9-azatricyclo [3.3.1.0<2,4>] nonane ring system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/46—8-Azabicyclo [3.2.1] octane; Derivatives thereof, e.g. atropine, cocaine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/04—Drugs for disorders of the alimentary tract or the digestive system for ulcers, gastritis or reflux esophagitis, e.g. antacids, inhibitors of acid secretion, mucosal protectants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/10—Laxatives
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/14—Prodigestives, e.g. acids, enzymes, appetite stimulants, antidyspeptics, tonics, antiflatulents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Engineering & Computer Science (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Nutrition Science (AREA)
  • Emergency Medicine (AREA)
  • Epidemiology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
AT06838207T 2005-11-22 2006-11-21 Carbamatverbindungen als agonisten am 5-ht4- rezeptor ATE448224T1 (de)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US73870205P 2005-11-22 2005-11-22
PCT/US2006/045099 WO2007062058A2 (en) 2005-11-22 2006-11-21 Carbamate compounds as 5-ht4 receptor agonists

Publications (1)

Publication Number Publication Date
ATE448224T1 true ATE448224T1 (de) 2009-11-15

Family

ID=38067868

Family Applications (1)

Application Number Title Priority Date Filing Date
AT06838207T ATE448224T1 (de) 2005-11-22 2006-11-21 Carbamatverbindungen als agonisten am 5-ht4- rezeptor

Country Status (20)

Country Link
US (2) US7329752B2 (de)
EP (1) EP1960396B1 (de)
JP (1) JP2009516745A (de)
KR (1) KR20080072727A (de)
CN (1) CN101312967B (de)
AR (1) AR057627A1 (de)
AT (1) ATE448224T1 (de)
AU (1) AU2006318507A1 (de)
BR (1) BRPI0618835A2 (de)
CA (1) CA2630222A1 (de)
DE (1) DE602006010432D1 (de)
EA (1) EA014819B1 (de)
ES (1) ES2336952T3 (de)
MY (1) MY143574A (de)
NO (1) NO20082597L (de)
NZ (1) NZ567653A (de)
PE (1) PE20070954A1 (de)
TW (1) TW200804366A (de)
WO (1) WO2007062058A2 (de)
ZA (1) ZA200804010B (de)

Families Citing this family (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP1871772B1 (de) * 2005-03-02 2014-09-10 Theravance, Inc. Chinolinverbindungen als agonisten des 5-ht4-rezeptors
ATE509021T1 (de) * 2006-02-16 2011-05-15 Theravance Inc Verfahren zur herstellung von zwischenverbindungen zu 5-ht4-rezeptoragonist- verbindungen

Family Cites Families (18)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5223511A (en) * 1987-09-23 1993-06-29 Boehringer Ingelheim Italia S.P.A. Benzimidazoline-2-oxo-1-carboxylic acid compounds useful as 5-HT receptor antagonists
IT1231413B (it) 1987-09-23 1991-12-04 Angeli Inst Spa Derivati dell'acido benzimidazolin-2-osso-1-carbossilico utili come antagonisti dei recettori 5-ht
JP3829879B2 (ja) * 1994-05-18 2006-10-04 大正製薬株式会社 キノリンカルボン酸誘導体
IT1275903B1 (it) * 1995-03-14 1997-10-24 Boehringer Ingelheim Italia Esteri e ammidi della 1,4-piperidina disostituita
US6069152A (en) * 1997-10-07 2000-05-30 Eli Lilly And Company 5-HT4 agonists and antagonists
IT1298271B1 (it) 1998-02-18 1999-12-20 Boehringer Ingelheim Italia Esteri ed ammidi dell'acido 2-oxo-2,3-diidro-benzimidazol-1- carbossilico
WO2000064441A2 (en) * 1999-04-28 2000-11-02 Respiratorius Ab Compound for use as a medicament for treatment of disorders involving bronchocontraction
IT1313625B1 (it) * 1999-09-22 2002-09-09 Boehringer Ingelheim Italia Derivati benzimidazolonici aventi affinita' mista per i recettori diserotonina e dopamina.
JP4181847B2 (ja) * 2002-10-25 2008-11-19 エルピーダメモリ株式会社 タイミング調整回路、半導体装置及びタイミング調整方法
CA2537127C (en) * 2003-09-03 2011-04-05 Pfizer Inc. Benzimidazolone compounds having 5-ht4 receptor agonistic activity
TW200533348A (en) * 2004-02-18 2005-10-16 Theravance Inc Indazole-carboxamide compounds as 5-ht4 receptor agonists
TWI351282B (en) * 2004-04-07 2011-11-01 Theravance Inc Quinolinone-carboxamide compounds as 5-ht4 recepto
JP5042028B2 (ja) * 2004-11-05 2012-10-03 セラヴァンス， インコーポレーテッド キノリノン−カルボキサミド化合物
ATE441646T1 (de) * 2004-11-05 2009-09-15 Theravance Inc 5-ht4-rezeptoragonistenverbindungen
US7419989B2 (en) * 2004-12-22 2008-09-02 Theravance, Inc. Indazole-carboxamide compounds
EP1871772B1 (de) * 2005-03-02 2014-09-10 Theravance, Inc. Chinolinverbindungen als agonisten des 5-ht4-rezeptors
US7351304B2 (en) * 2005-05-24 2008-04-01 General Electric Company Method and apparatus for reducing surface defects
DE602006019595D1 (de) 2005-06-07 2011-02-24 Theravance Inc Benzimidazoloncarbonsäureamidverbindungen als agonisten des 5-ht4-rezeptors

Also Published As

Publication number Publication date
EP1960396B1 (de) 2009-11-11
AR057627A1 (es) 2007-12-05
US20070117796A1 (en) 2007-05-24
US7329752B2 (en) 2008-02-12
EA200801402A1 (ru) 2008-10-30
JP2009516745A (ja) 2009-04-23
BRPI0618835A2 (pt) 2011-09-13
US7851467B2 (en) 2010-12-14
NO20082597L (no) 2008-06-10
CA2630222A1 (en) 2007-05-31
WO2007062058A2 (en) 2007-05-31
AU2006318507A1 (en) 2007-05-31
KR20080072727A (ko) 2008-08-06
EA014819B1 (ru) 2011-02-28
ES2336952T3 (es) 2010-04-19
PE20070954A1 (es) 2007-09-10
MY143574A (en) 2011-05-31
CN101312967B (zh) 2011-08-24
WO2007062058A3 (en) 2007-09-07
NZ567653A (en) 2011-06-30
DE602006010432D1 (de) 2009-12-24
EP1960396A2 (de) 2008-08-27
CN101312967A (zh) 2008-11-26
US20080090811A1 (en) 2008-04-17
ZA200804010B (en) 2009-02-25
TW200804366A (en) 2008-01-16

Similar Documents

Publication Publication Date Title
FIC20230027I1 (fi) Tremelimumabi
ATE549350T1 (de) Neuropeptid-2-rezeptor-agonisten
DE602006007563D1 (de) Agonisten
DK1863818T3 (da) Acetylenyl-pyrazolo-pyrimidinderivater som mglur2-antagonister
NL1031385A1 (nl) Gesubstitueerde sulfonylaminoarylmethylcyclopropaancarbonamideverbindingen.
FI20050189A0 (fi) Kiinnityssovitelma
CR10089A (es) Compuestos miméticos de lisina modificados
DK1973886T3 (da) Prokineticin-1-receptor-antagonister
NL1031335A1 (nl) Gesubstitueerde N-sulfonylaminofenylethyl-2-fenoxyaceetamideverbindingen.
DE602006020447D1 (de) Niacin-rezeptoragonisten, zusammensetzungen mit de
DE502006004001D1 (de) Wägevorrichtung, insbesondere mehrspur-wägevorrichtung
ATE535523T1 (de) Benzimidazolcarbonsäureamid-verbindungen als 5- ht4 rezeptor-agonisten
ES1064680Y (es) Estructura portante de receptor
DE602006015186D1 (de) Oxindole als kinaseinhibitoren
FI6681U1 (fi) Palkki
FI20055133A (fi) Iskulaite
ATE448224T1 (de) Carbamatverbindungen als agonisten am 5-ht4- rezeptor
DE502006002822D1 (de) Ges
ES1060653Y (es) Estructura de cerramiento para la construccion.
FR2884161B1 (fr) Architecture de machine-outil
ES1060081Y (es) Pieza para construccion.
FR2883126B1 (fr) Binette multifonction
NL1033153A1 (nl) ES-las kwaliteitbewakingsysteem.
ES1061869Y (es) Bisagra de capo.
ES1061058Y (es) Bisagra de capo.

Legal Events

Date Code Title Description
RER Ceased as to paragraph 5 lit. 3 law introducing patent treaties